udca
Showing 1 - 13 of 13
Diabetes Trial in Xi'an (UDCA)
Recruiting
- Diabetes Mellitus
- UDCA
-
Xi'an, Shanxi, ChinaFirst Affiliated Hospital of Xi'an Jiaotong University
Aug 11, 2022
Primary Biliary Cirrhosis Trial in Beijing (Fenofibrate, UDCA)
Withdrawn
- Primary Biliary Cirrhosis
- Fenofibrate
- UDCA
-
Beijing, ChinaBeijing 302 hospital
Sep 12, 2021
Primary Biliary Cholangitis Trial in Xi'an (Fenofibrate 200mg, Placebo, UDCA)
Recruiting
- Primary Biliary Cholangitis
- Fenofibrate 200mg
- +2 more
-
Xi'an, Shaanxi, ChinaXijing Hospital
Mar 3, 2023
Primary Biliary Cirrhosis Trial in Changchun (Obeticholic Acid Tablets, UDCA, Placebo)
Recruiting
- Primary Biliary Cirrhosis
- Obeticholic Acid Tablets
- +2 more
-
Changchun, Jilin, ChinaThe first hospital of Jilin University
Jul 23, 2021
Primary Biliary Cholangitis Trial in Beijing (Obeticholic Acid Tablets(OCA), UDCA, Placebo)
Recruiting
- Primary Biliary Cholangitis
- Obeticholic Acid Tablets(OCA)
- +2 more
-
Beijing, ChinaBeijing Friendship Hospital
Jul 7, 2022
Healthy Trial in Amsterdam (UDCA)
Completed
- Healthy
- UDCA
-
Amsterdam, NetherlandsBeuers
May 3, 2019
Primary Sclerosing Cholangitis Trial (UCMSC, UDCA)
Active, not recruiting
- Primary Sclerosing Cholangitis
- UCMSC
- UDCA
- (no location specified)
Apr 23, 2018
Primary Biliary Cirrhosis Trial in Xi'an (Fuzhenghuayu, UDCA)
Unknown status
- Primary Biliary Cirrhosis
- Fuzhenghuayu
- UDCA
-
Xi'an, Shaanxi, ChinaXijing Hosipital of Digestive Disease
Sep 26, 2016
Primary Biliary Cirrhosis Trial in Xi'an (Fuzhenghuayu, UDCA)
Unknown status
- Primary Biliary Cirrhosis
- Fuzhenghuayu
- UDCA
-
Xi'an, Shaanxi, ChinaXijing Hosipital of Digestive Disease
Sep 26, 2016
Primary Biliary Cirrhosis Trial in Xi'an (Fenofibrate, UDCA)
Unknown status
- Primary Biliary Cirrhosis
- Fenofibrate
- UDCA
-
Xi'an, Shaanxi, ChinaXijing Hosipital
Jul 5, 2016
Primary Biliary Cirrhosis Trial in Xi'an (Fenofibrate, UDCA)
Unknown status
- Primary Biliary Cirrhosis
- Fenofibrate
- UDCA
-
Xi'an, Shaanxi, ChinaXijing Hosipital
Jul 5, 2016
Type 2 Diabetes, Chronic Liver Disease Trial in Kanazawa (UDCA, Sitagliptin)
Unknown status
- Type 2 Diabetes Mellitus
- Chronic Liver Disease
- UDCA
- Sitagliptin
-
Kanazawa, Ishikawa, JapanInternal medicine, Kanazawa university hospital
Apr 15, 2011